Gilead inks deal with generics manufacturers to expand HIV drug access, J&J announces layoffs, Amgen sued for hiding $10.7B tax bill [The good, the bad, the ugly]

Off Script: A Pharma Manufacturing Podcast

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:

The good — Gilead inks deal with generics manufacturers to expand HIV drug access

The bad — J&J announces layoffs at New Brunswick headquarters

The ugly — Amgen sued for hiding $10.7B tax bill